Maulee Hiromi Arambewela il 25/12/2024

Young-Onset Diabetes in Sri Lanka: Experience From the Developing World

J Diabetes Res. 2024 Dec 17;2024:7557153. doi: 10.1155/jdr/7557153. eCollection 2024.ABSTRACTBackground: Young-onset diabetes (YOD) is characterised by unique diagnostic and management challenges more pronounced in resource-limited settings like Sri Lanka. Aims: We aimed to ascertain the prevalence,

Yanhua Li il 25/12/2024

Sclerostin as a new target of diabetes-induced osteoporosis

Front Endocrinol (Lausanne). 2024 Dec 10;15:1491066. doi: 10.3389/fendo.2024.1491066. eCollection 2024.ABSTRACTSclerostin, a protein synthesized by bone cells, is a product of the SOST gene. Sclerostin is a potent soluble inhibitor of the WNT signaling pathway, and is known to inhibit bone formation

Weike Chen il 25/12/2024

Supramolecular Peptide Depots for Glucose-Responsive Glucagon Delivery

J Biomed Mater Res A. 2025 Jan;113(1):e37854. doi: 10.1002/jbm.a.37854.ABSTRACTPrecise blood glucose control continues to be a critical challenge in the treatment and management of type 1 diabetes in order to mitigate both acute and chronic complications. This study investigates the development of a

Kelli M Richardson il 24/12/2024

The efficacy of using continuous glucose monitoring as a behaviour change tool in populations with and without diabetes: a systematic review and meta-analysis of randomised controlled trials

Int J Behav Nutr Phys Act. 2024 Dec 23;21(1):145. doi: 10.1186/s12966-024-01692-6.ABSTRACTBACKGROUND: Continuous glucose monitoring (CGM) holds potential as a precision public health intervention, offering personalised insights into how diet and physical activity affect glucose levels. Nevertheless,

Yogish C Kudva il 23/12/2024

Automated Insulin Delivery in Older Adults with Type 1 Diabetes

NEJM Evid. 2025 Jan;4(1):EVIDoa2400200. doi: 10.1056/EVIDoa2400200. Epub 2024 Dec 23.ABSTRACTBACKGROUND: Older adults with type 1 diabetes are at risk for serious hypoglycemia. Automated insulin delivery can reduce risk but has not been sufficiently evaluated in this population.METHODS: We conducted

Kamel Mohammedi il 21/12/2024

Genetic predisposition to nephropathy and associated cardiovascular disease in people with type 1 diabetes: role of the angiotensinI-converting enzyme (ACE), and beyond; a narrative review

Cardiovasc Diabetol. 2024 Dec 21;23(1):453. doi: 10.1186/s12933-024-02544-0.ABSTRACTHypertension, cardiovascular disease and kidney failure are associated with persistent hyperglycaemia and the subsequent development of nephropathy in people with diabetes. Diabetic nephropathy is associated with wid